Dexamethasone and oxygen therapy in care home residents with diabetes: a management guide and algorithm for treatment: a rapid response action statement from the European Diabetes Working Party for Older People (EDWPOP) and European Geriatric Medicine Society (EuGMS)

Aging Clin Exp Res. 2021 Apr;33(4):895-900. doi: 10.1007/s40520-021-01822-1. Epub 2021 Apr 15.

Abstract

This statement addresses the need to provide clinically relevant and practical guidance for long-term care staff working in care homes and other stakeholders engaged in the care of residents who require consideration for dexamethasone and oxygen therapy. It had been provided following a series of consensus discussions between the EDWPOP and the EuGMS in January and February 2021. Its main aim is to minimise morbidity and mortality from serious acute illnesses including COVID-19 requiring these treatments within the long-term care sector.

Keywords: COVID-19; Dexamethasone; Diabetes; Long-term care; Oxygen.

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Algorithms
  • COVID-19 Drug Treatment*
  • Dexamethasone / therapeutic use
  • Diabetes Mellitus*
  • Humans
  • Oxygen
  • SARS-CoV-2

Substances

  • Dexamethasone
  • Oxygen